Bio-Techne (TECH) Short-Term Debt repayments (2014 - 2026)

Bio-Techne (TECH) recorded quarterly Short-Term Debt repayments of $60.0 million in Q1 2026, up 50.0% quarter-over-quarter from $40.0 million in Q4 2025, and up 650.0% on a YoY basis from $8.0 million in Q1 2025.

Bio-Techne (TECH) Short-Term Debt repayments (2014 - 2026) Analysis & Trends

Bio-Techne's Short-Term Debt repayments history runs 13 years deep, the most recent figure standing at $60.0 million for Q1 2026.

  • In Q1 2026, Short-Term Debt repayments rose 650.0% year-over-year to $60.0 million; the TTM figure through Mar 2026 stood at $196.0 million (up 102.06% YoY), while the FY2025 annual figure was $77.0 million, down 69.92% from the prior year.
  • Short-Term Debt repayments was $60.0 million for Q1 2026 at Bio-Techne, up from $40.0 million in the prior quarter.
  • In the past five years, Short-Term Debt repayments ranged from a high of $441.0 million in Q3 2022 to a low of $3.1 million in Q2 2022.
  • Historically, Short-Term Debt repayments has averaged $71.4 million across 5 years, with a median of $58.0 million in 2023.
  • Biggest YoY gain for Short-Term Debt repayments was 762.59% in 2022; the steepest drop was 97.6% in 2022.
  • A 5-year view of Short-Term Debt repayments shows it stood at $64.7 million in 2022, then dropped by 10.3% to $58.0 million in 2023, then tumbled by 67.24% to $19.0 million in 2024, then jumped by 110.53% to $40.0 million in 2025, then surged by 50.0% to $60.0 million in 2026.
  • The last three Short-Term Debt repayments figures came in at $60.0 million (Q1 2026), $40.0 million (Q4 2025), and $46.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt repayments (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 102,000.00
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -
9 Abivax 90.15 Bn 90.15 Bn - -482,347.21
10 Bio-Techne 8.41 Bn 8.20 Bn 208.29 Mn 60.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 60.00 Mn
Mar 31, 2026 60.00 Mn
Dec 31, 2025 40.00 Mn
Dec 31, 2025 40.00 Mn
Sep 30, 2025 46.00 Mn
Sep 30, 2025 46.00 Mn
Jun 30, 2025 50.00 Mn
Jun 30, 2025 50.00 Mn
Mar 31, 2025 8.00 Mn
Mar 31, 2025 8.00 Mn
Sep 30, 2024 19.00 Mn
Sep 30, 2024 19.00 Mn
Jun 30, 2024 70.00 Mn
Jun 30, 2024 70.00 Mn
Mar 31, 2024 58.00 Mn
Mar 31, 2024 58.00 Mn
Dec 31, 2023 58.00 Mn
Dec 31, 2023 58.00 Mn
Sep 30, 2023 70.00 Mn
Sep 30, 2023 70.00 Mn